Enanta Pharmaceuticals (ENTA) Earnings Date, Estimates & Call Transcripts → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free ENTA Stock Alerts $13.51 -0.70 (-4.93%) (As of 03/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 7) -$1.58 Missed By -$0.40 Consensus EPS (Feb. 7) -$1.18 Get Enanta Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ENTA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueENTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ENTA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThe ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Enanta Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($2.32)($1.35)($1.84) Q2 20242($2.63)($1.31)($1.97) Q3 20242($1.46)($0.91)($1.19) Q4 20242($1.05)($0.72)($0.89) FY 20248($7.46)($4.29) ($5.88)ENTA Earnings Date and InformationEnanta Pharmaceuticals last posted its quarterly earnings data on February 7th, 2024. The biotechnology company reported ($1.58) earnings per share for the quarter, missing analysts' consensus estimates of ($1.18) by $0.40. The business earned $18 million during the quarter, compared to analysts' expectations of $22.74 million. Enanta Pharmaceuticals has generated ($6.56) earnings per share over the last year (($6.56) diluted earnings per share). Earnings for Enanta Pharmaceuticals are expected to grow in the coming year, from ($4.90) to ($4.55) per share. Enanta Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More Enanta Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/7/2024Q1 2024($1.18)($1.58)($0.40)($1.58)$22.74 million$18.00 million11/20/2023Q3 2023($2.11)($1.33)+$0.78($1.33)$17.93 million$18.93 million 8/7/2023Q3 2023($2.38)($1.86)+$0.52($1.86)$15.88 million$18.89 million5/8/2023Q2 2023($1.91)($1.79)+$0.12($1.79)$19.06 million$17.80 million 2/7/2023Q1 2023($1.52)($1.39)+$0.13($1.39)$22.48 million$23.60 million 11/21/2022Q4 2022($1.37)($1.27)+$0.10($1.27)$22.86 million$20.32 million Get the Latest News and Ratings for ENTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q3 2022($1.36)($1.53)($0.17)($1.53)$20.73 million$19.48 million 5/9/2022Q2 2022($1.43)($1.63)($0.20)($1.63)$20.40 million$18.72 million 2/8/2022Q1 2022($1.13)($1.48)($0.35)($1.48)$26.34 million$27.60 million 11/22/2021Q3 2021($1.31)($1.22)+$0.09($1.22)$35.65 million$23.58 million 8/5/2021Q2 2021($1.41)($1.19)+$0.22($1.19)$21.87 million$21.62 million 5/6/2021Q1 2021($0.94)($1.09)($0.15)($1.09)$25.05 million$20.10 million Enanta Pharmaceuticals Earnings - Frequently Asked Questions When is Enanta Pharmaceuticals's earnings date? Enanta Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on ENTA's earnings history. Did Enanta Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Enanta Pharmaceuticals (NASDAQ:ENTA) missed the analysts' consensus estimate of ($1.18) by $0.40 with a reported earnings per share (EPS) of ($1.58). Learn more on analysts' earnings estimate vs. ENTA's actual earnings. How much revenue does Enanta Pharmaceuticals generate each year? Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded annual revenue of $79.20 million. How much profit does Enanta Pharmaceuticals generate each year? Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded net income of -$133.82 million. ENTA has generated -$6.56 earnings per share over the last four quarters. What is Enanta Pharmaceuticals's EPS forecast for next year? Enanta Pharmaceuticals's earnings are expected to grow from ($4.90) per share to ($4.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Xeris Biopharma Earnings Gossamer Bio Earnings Atai Life Sciences Earnings Stoke Therapeutics Earnings AC Immune Earnings XOMA Earnings Erasca Earnings Nature's Sunshine Products Earnings PepGen Earnings Kamada Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:ENTA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.